Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 4 1

Status

Completed 3

Sponsor Class

OTHER 3

Study Type

Observational 5Interventional 3

Sponsor

Cancer Type

Endocrine 2

Conditions

Breast Neoplasms 5004Neoplasms 4197Prostatic Neoplasms 2428Carcinoma, Non-Small-Cell Lung 2265Colorectal Neoplasms 2053Lung Neoplasms 1705Multiple Myeloma 1459Lymphoma 1405Leukemia, Myeloid, Acute 1382Neoplasm Metastasis 1374Melanoma 1270Pancreatic Neoplasms 1200Leukemia 1196Ovarian Neoplasms 1192Lymphoma, Non-Hodgkin 1132Precursor Cell Lymphoblastic Leukemia-Lymphoma 1091Head and Neck Neoplasms 1056Leukemia, Lymphocytic, Chronic, B-Cell 994Lymphoma, Follicular 897Colonic Neoplasms 895Brain Neoplasms 876Stomach Neoplasms 857Recurrence 853Carcinoma, Hepatocellular 846Glioblastoma 841Lymphoma, Large B-Cell, Diffuse 771Rectal Neoplasms 759Uterine Cervical Neoplasms 728Carcinoma, Renal Cell 705Hodgkin Disease 698

Interventions

Tolvaptan 1Sugars 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Interventional × Hyponatremia × Clear all
NCT03636568 2024-07-23

DHAPS

Washington University School of Medicine

Phase NA Completed
300 enrolled
Endocrine

Hyponatremia, Pituitary Diseases, Pituitary Neoplasms

NCT01199198 2020-09-23

Tolvaptan in Hyponatremic Cancer Patients

M.D. Anderson Cancer Center

Phase 4 Completed
52 enrolled 7 charts

Hyponatremia

NCT02727686 2019-11-25

Post-Operative Water Load Following Transsphenoidal Pituitary Surgery

St. Joseph's Hospital and Medical Center, Phoenix

Phase NA Completed
30 enrolled
Endocrine

Hyponatremia, Pituitary Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡